Press Releases

EXL Reports 2011 Fourth Quarter and Full Year Results and Provides Guidance for Calendar Year 2012

29 Feb 2012 07:23 | Press Releases

2011 Revenues of $360.5 Million and Adjusted Operating Margin of 15.3% 2012 Revenue Guidance of $445.0 Million to $455.0 Million 2012 Adjusted Diluted EPS Guidance of $1.50 to $1.55 NEW YORK, Feb. 28, 2012 (CRWENEWSWIRE) -- ExlService Holdings, ... | Read

Coronado Biosciences Announces Phase 1 Clinical Trial Results for TSO in Crohn’s Disease

28 Feb 2012 01:26 | Press Releases

BURLINGTON, Mass., Feb. 28, 2012 (CRWENEWSWIRE) -- Coronado Biosciences, Inc., (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announ ... | Read

JA Solar Announces Preliminary Unaudited Shipment Results for the Fourth Quarter of 2011

28 Feb 2012 01:04 | Press Releases

  SHANGHAI, China, Feb. 28, 2012 (CRWENEWSWIRE) -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or the "Company"), one of the world's largest manufacturers of high-performance solar cells and solar power products, today announced ... | Read

pSivida Corp. Announces Positive Outcome to European Decentralized Procedure for Approval of ILUVIEN® for the Treatment of Chronic Diabetic Macular Edema

28 Feb 2012 12:53 | Press Releases

  * ILUVIEN(R) expected to be the first sustained release pharmaceutical in the European Union (EU) to treat diabetic macular edema (DME) * ILUVIEN expected to be indicated for chronic DME considered insufficiently responsive to avail ... | Read

Meridian Bioscience Receives FDA Clearance for New Legionella Test

28 Feb 2012 08:44 | Press Releases

  CINCINNATI -- 02/27/2012 (CRWENEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has received FDA clearance from the U.S. Food and Drug Administration (FDA) for TRU Legionellaâ„¢, a new rapid assay for detection ... | Read